Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
出版年份 2016 全文链接
标题
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
作者
关键词
Medulloblastoma, Subgroups, WNT, SHH, Group 3, Group 4, p53, Genomics, Outcomes
出版物
ACTA NEUROPATHOLOGICA
Volume 131, Issue 6, Pages 821-831
出版商
Springer Nature
发表日期
2016-04-04
DOI
10.1007/s00401-016-1569-6
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC- Driven Medulloblastoma
- (2016) Yanxin Pei et al. CANCER CELL
- Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
- (2016) Eric M Thompson et al. LANCET ONCOLOGY
- Divergent clonal selection dominates medulloblastoma at recurrence
- (2016) A. Sorana Morrissy et al. NATURE
- Combined MYC and P53 Defects Emerge at Medulloblastoma Relapse and Define Rapidly Progressive, Therapeutically Targetable Disease
- (2015) Rebecca M. Hill et al. CANCER CELL
- Neuropsychological Outcome of Children Treated for Standard Risk Medulloblastoma in the PNET4 European Randomized Controlled Trial of Hyperfractionated Versus Standard Radiation Therapy and Maintenance Chemotherapy
- (2015) Hugo Câmara-Costa et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog–Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032
- (2015) Giles W. Robinson et al. JOURNAL OF CLINICAL ONCOLOGY
- Medulloblastoma subgroup-specific outcomes in irradiated children: who are the true high-risk patients?
- (2015) Vijay Ramaswamy et al. NEURO-ONCOLOGY
- Molecular stratification of medulloblastoma: comparison of histological and genetic methods to detect Wnt activated tumours
- (2015) Tobias Goschzik et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- p53 and Medulloblastoma
- (2015) Vijay Ramaswamy et al. Cold Spring Harbor Perspectives in Medicine
- Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma
- (2015) Jonas Ecker et al. Acta Neuropathologica Communications
- Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort
- (2014) Torsten Pietsch et al. ACTA NEUROPATHOLOGICA
- Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition
- (2014) Marcel Kool et al. CANCER CELL
- Cytogenetic Prognostication Within Medulloblastoma Subgroups
- (2014) David J.H. Shih et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of Craniospinal Dose, Boost Volume, and Neurologic Complications on Intellectual Outcome in Patients With Medulloblastoma
- (2014) Iska Moxon-Emre et al. JOURNAL OF CLINICAL ONCOLOGY
- Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma
- (2014) Paul A. Northcott et al. NATURE
- WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma
- (2014) Nataliya Zhukova et al. Acta Neuropathologica Communications
- Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group
- (2013) Nicholas G. Gottardo et al. ACTA NEUROPATHOLOGICA
- DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies
- (2013) Edward C. Schwalbe et al. ACTA NEUROPATHOLOGICA
- BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma
- (2013) P. Bandopadhayay et al. CLINICAL CANCER RESEARCH
- Quality of Survival and Growth in Children and Young Adults in the PNET4 European Controlled Trial of Hyperfractionated Versus Conventional Radiation Therapy for Standard-Risk Medulloblastoma
- (2013) Colin Kennedy et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Subgroup-Specific Prognostic Implications ofTP53Mutation in Medulloblastoma
- (2013) Nataliya Zhukova et al. JOURNAL OF CLINICAL ONCOLOGY
- High-Risk Medulloblastoma: A Pediatric Oncology Group Randomized Trial of Chemotherapy Before or After Radiation Therapy (POG 9031)
- (2013) Nancy J. Tarbell et al. JOURNAL OF CLINICAL ONCOLOGY
- Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis
- (2013) Vijay Ramaswamy et al. LANCET ONCOLOGY
- Real-time PCR assay based on the differential expression of microRNAs and protein-coding genes for molecular classification of formalin-fixed paraffin embedded medulloblastomas
- (2013) Ratika Kunder et al. NEURO-ONCOLOGY
- Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
- (2012) Marcel Kool et al. ACTA NEUROPATHOLOGICA
- Hyperfractionated Versus Conventional Radiotherapy Followed by Chemotherapy in Standard-Risk Medulloblastoma: Results From the Randomized Multicenter HIT-SIOP PNET 4 Trial
- (2012) Birgitta Lannering et al. JOURNAL OF CLINICAL ONCOLOGY
- HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment
- (2012) Till Milde et al. JOURNAL OF NEURO-ONCOLOGY
- Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations
- (2012) Trevor J. Pugh et al. NATURE
- Novel mutations target distinct subgroups of medulloblastoma
- (2012) Giles Robinson et al. NATURE
- Dissecting the genomic complexity underlying medulloblastoma
- (2012) David T. W. Jones et al. NATURE
- Clonal selection drives genetic divergence of metastatic medulloblastoma
- (2012) Xiaochong Wu et al. NATURE
- Subgroup-specific structural variation across 1,000 medulloblastoma genomes
- (2012) Paul A. Northcott et al. NATURE
- Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children's Oncology Group trial A9961
- (2012) Roger J. Packer et al. NEURO-ONCOLOGY
- Radiation therapy quality in CCG/POG intergroup 9961: implications for craniospinal irradiation and the posterior fossa boost in future medulloblastoma trials
- (2012) Bernadine Donahue et al. Frontiers in Oncology
- Biological and clinical heterogeneity of MYCN-amplified medulloblastoma
- (2011) Andrey Korshunov et al. ACTA NEUROPATHOLOGICA
- Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
- (2011) David W. Ellison et al. ACTA NEUROPATHOLOGICA
- Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples
- (2011) Paul A. Northcott et al. ACTA NEUROPATHOLOGICA
- Molecular subgroups of medulloblastoma: the current consensus
- (2011) Michael D. Taylor et al. ACTA NEUROPATHOLOGICA
- Predicting Relapse in Patients With Medulloblastoma by Integrating Evidence From Clinical and Genomic Features
- (2011) Pablo Tamayo et al. JOURNAL OF CLINICAL ONCOLOGY
- Adult Medulloblastoma Comprises Three Major Molecular Variants
- (2011) Marc Remke et al. JOURNAL OF CLINICAL ONCOLOGY
- FSTL5Is a Marker of Poor Prognosis in Non-WNT/Non-SHH Medulloblastoma
- (2011) Marc Remke et al. JOURNAL OF CLINICAL ONCOLOGY
- Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study
- (2011) Anita Villani et al. LANCET ONCOLOGY
- Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical Outcome
- (2010) Yoon-Jae Cho et al. JOURNAL OF CLINICAL ONCOLOGY
- Definition of Disease-Risk Stratification Groups in Childhood Medulloblastoma Using Combined Clinical, Pathologic, and Molecular Variables
- (2010) David W. Ellison et al. JOURNAL OF CLINICAL ONCOLOGY
- Medulloblastoma Comprises Four Distinct Molecular Variants
- (2010) Paul A. Northcott et al. JOURNAL OF CLINICAL ONCOLOGY
- Medulloblastoma Variants: Age-Dependent Occurrence and Relation to Gorlin Syndrome--A New Clinical Perspective
- (2009) M. L. Garre et al. CLINICAL CANCER RESEARCH
- Hyperfractionated Accelerated Radiotherapy in the Milan Strategy for Metastatic Medulloblastoma
- (2008) Lorenza Gandola et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started